BCG | Nature is moving to the top of the C-suite agenda. BCG associate director Dean Muruven sat down with Erin Billman, executive director of the Science Based Targets Network (SBTN) and Edith Martin, global biodiversity lead at Quantis (a BCG company), to discuss the opportunity for businesses to help address the crisis unfolding in the natural world.

Latest resources

What nature-related risks does the pharma industry face?
By protecting biodiversity and natural ecosystems, the pharmaceutical industry can mitigate risks and build long-term resilience.

World Cocoa Foundation publishes first ever greenhouse gas accounting standard for the cocoa sector
World Cocoa Foundation & Quantis launch first-ever GHG standard, helping the cocoa sector measure, report, and cut emissions consistently.

Accelerating progress to 2030 climate targets
Allon Zeitoun and Géraldine Noé sit down to discuss the progress made, challenges ahead and what companies can do to accelerate action to 2030 targets.